National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.
Toxicol Lett. 2010 Nov 30;199(2):111-4. doi: 10.1016/j.toxlet.2010.08.019. Epub 2010 Sep 8.
Ecotoxicity testing of pesticide active ingredients and formulated plant protection products (PPPs) prior to their commercial use is required by authorities around the world. Such studies are important for the conduct of risk assessments to protect wildlife and the environment, but they should only be conducted when their use is scientifically justified. One test of questionable scientific merit is the chronic fish toxicity test when conducted with formulated PPPs, which is a potential requirement under European legislation: chronic exposure to the formulated product per se rarely occurs in the environment and therefore it is generally not possible to use the data from chronic formulation studies in a meaningful risk assessment. A recent survey of European crop protection companies to explore the scientific merits and regulatory drivers for chronic fish toxicity studies has shown that current practice in deciding on the need for chronic fish toxicity testing of formulated PPPs varies substantially between companies. The most commonly cited reason for conducting such studies was solely to meet regulatory requirements. We conclude that chronic formulation testing is rarely if ever scientifically justified, and recommend that the forthcoming revision of the EU Aquatic Toxicology Guidance Document takes account of this by including a requirement that justification must be provided for conducting the test, rather than the current situation where the onus is on the registrant to provide a justification for not conducting the test.
在农药活性成分和配制成的植保产品(PPPs)投入商业使用之前,世界各国的主管部门都要求进行生态毒性测试。这些研究对于进行风险评估以保护野生动植物和环境非常重要,但只有在其使用具有科学依据的情况下才应进行此类研究。一种具有可疑科学价值的测试是用配制成的 PPP 进行的慢性鱼类毒性测试,这是欧洲法规的潜在要求:在环境中,慢性暴露于配制品本身很少发生,因此通常不可能在有意义的风险评估中使用慢性配方研究的数据。最近对欧洲作物保护公司进行的一项调查,旨在探讨慢性鱼类毒性研究的科学价值和监管驱动因素,表明目前在决定是否需要对配制成的 PPP 进行慢性鱼类毒性测试方面,各公司之间存在很大差异。进行此类研究的最常见原因仅仅是为了满足法规要求。我们的结论是,慢性配方测试很少有科学依据,如果有的话,我们建议即将修订的欧盟水生毒理学指导文件考虑到这一点,要求在进行测试时必须提供理由,而不是目前的情况,即注册人有责任提供不进行测试的理由。